References
Krieger JN, Nyberg L Jr, Nickel JC, et al. NIH consensus definition and classification of prostatitis. JAMA 1999; 282(3): 236–7
Pontari MA. Chronic prostatitis/chronic pelvic pain syndrome in elderly men. Drugs Aging 2003; 20(1): 1111–25
Schaeffer AJ, Landis JR, Knauss JS, et al. Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol 2002; 168(2): 593–8
Calhoun E, Collins MM, Pontari M, et al. What is the economic impact of chronic prostatitis [abstract]. J Urol 2001; 165 Suppl. 5: 25
Pontari MA, Litwin MS, O’Leary MP, et al. A case-control study of epidemiological factors in men with chronic pelvic pain syndrome [abstract]. J Urol 2002; 167 Suppl. 4: 24
Nickel JC, Alexander RB, Schaeffer AJ, et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003; 170(3): 818–22
Schaeffer AJ, Knauss JS, Landis JR, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002; 168(3): 1048–53
Nickel JC. Clinical evaluation of the man with chronic prostatitis/ chronic pelvic pain syndrome. Urology 2002; 60 Suppl. 6A: 20–3
Bjerklund Johanson TE, Gruneberg RN, Guibert J, et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 1998; 34(6): 457–66
Narayan P, McKay J, Doyle C. A six-week double-blind pilot study of tamsulosin versus placebo in patients with chronic non-bacterial prostatitis/chronic pelvic pain [abstract]. J Urol 2002; 167 Suppl. 4: 24
Nickel JC, Pontari M, Moon T, et al. A randomized, placebo-controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003; 169(4): 1401–5
Nickel JC, Forrest J, Tomera KM, et al. Effects of pentosanpolysulfate sodium in men with chronic pelvic pain syndrome: a multicenter randomized placebo-controlled study: on behalf of the North American PPS-CPPS Investigator Group [abstract]. J Urol 2002; 167 Suppl. 4: 63
Downey J, Nickel JC, Pontari MA, et al. Randomized placebo-controlled multi-center pilot study to evaluate the safety and efficacy of finasteride in the treatment of male chronic pelvic pain syndrome: category IIIA CPPS (chronic nonbacterial prostatitis) [abstract]. J Urol 2002; 167 Suppl. 4: 26
Shoskes DA. Phytotherapy in chronic prostatitis. Urology 2002; 60 Suppl. 6A; 35–7
Shoskes DA, Zeitlin SI, Shahed A, et al. Quercetin in men with category III chronic prostatitis: a preliminary, prospective, double-blind, placebo-controlled trial. Urology 1999; 54(6): 960–3
Volpe MA, Cabelin M, Te AE, et al. A prospective trial using saw palmetto versus finasteride in the treatment of chronic nonbacterial prostatitis (CP). J Urol 2001; 165: 27–8
Sasaki K, Smith CP, Chuang YC, et al. Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol 2001; 7(1): 47–9
Zeitlin SI. Heat therapy in the treatment of prostatitis. Urology 2002; 60 Suppl. 6A: 38–41
Rights and permissions
About this article
Cite this article
Chronic prostatitis/chronic pelvic pain syndrome: still lots to learn about its aetiology, evaluation and treatment. Drugs Ther. Perspect 20, 11–14 (2004). https://doi.org/10.2165/00042310-200420110-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200420110-00004